BENGALURU, India, Aug. 26, 2024 /PRNewswire/ — Microland, India’s networking pioneer and India’s largest specialized IT infrastructure services and consulting company, is celebrating 35 years of providing technological innovation to global business leaders.

 
Established in 1989, Microland was the first company in India to introduce global networking giants and other technology leaders—such as Novell NetWare, Cisco, Compaq, and Netscape—to the country. Today, with its industry-leading growth and specialization in next-generation technologies such as AI, automated operations, and platform-driven solutions, Microland drives operational excellence, agility, resilience, and productivity for enterprises worldwide. Over 4,600 Microlanders deliver services in more than 100 countries across Asia, Australia, Europe, the Middle East, and North America, offering cutting-edge solutions in networks, cloud, data centers, cybersecurity, services management, applications, and automation.
Microland has continuously evolved over the last 35 years, staying ahead of technology developments to reshape itself and build on its global recognition. Today, as the company marks its 35th anniversary, it returns to its roots as a networking pioneer, shifting its focus from ‘Make digital happen’ to ‘Connect with the best.’ Microland realizes that organizations are well on their way to realizing digital adoption. They know that networks underpin the functionality and efficiency of modern digital systems, supporting productivity and innovation at the most fundamental level.
To aid the journey of its clients across a business landscape that demands continuous innovation, Microland has embraced AI. Its latest AI-powered Intelligeni platform represents a groundbreaking shift in IT service operations. At its core, Intelligeni embodies Microland’s commitment to innovation, efficiency, and client-centricity. It empowers client organizations with unprecedented insights, proactive problem-solving, unique experience, and autonomous decision-making capabilities. With seven modules, Intelligeni delivers 10x more resilient and efficient digital infrastructure. The Intelligeni platform has been recognized as an Innovator in Avasant’s RadarView™ ITOps Services for 2023-24. Engineered and perfected over the last decade, the platform harnesses AI, leading the way to a first-of-its-kind IT services administrator.
Microland has firmly placed itself on the radar of several leading industry bodies and analysts. It has been recognized globally as a Leader in the Gartner Magic Quadrant for Managed Network Services for four years in a row (2020, 2021, 2022, 2023). Based on rigorous, fact-based analysis, Gartner’s Magic Quadrant allows technology users to assess the market and its technology providers, understand their differentiators, and narrow their buying choices.
In early August 2024, Microland was awarded the prestigious World Class 5-star rating by the Service Desk Institute (SDI) for the quality of IT service and support operations. Microland is the third company globally and the first company in India to attain this accolade.
Microland has also achieved a gold rating from EcoVadis, underscoring its exceptional performance in Environment and Sustainable Procurement, reflecting its commitment to high Environmental, Social, and Governance (ESG) standards. At Microland, cutting-edge AI technology is integrated into every facet of its operations and customer solutions. It is complemented by a focus on embedding sustainability principles throughout all practices, from innovation to implementation. The gold rating from EcoVadis places Microland in the top 5 percent of over 125,000 assessed companies globally.
Microland has sharpened its approach to ESG with the Microland Foundation. This dedicated social development arm forges meaningful partnerships to conceptualize and implement projects that solve society’s most pressing problems around education, environment, employability, and health in a measurable, scalable, and sustainable manner. The Foundation uses Microland’s technological capabilities to deliver, monitor, and scale its programs.
In a message to Microland on its 35th anniversary, Peter Bendor-Samuel, Founder of Everest Group, said, “Microland excels at integrating technology with services. Where others would use labor, it uses the platforms it has invested in and developed in-house to deliver the services. Result: They are able to deliver robust, high-quality services at lower costs. This pushes them forward as a leader in the technology services space and ensures they can compete with much bigger firms.”
Speaking on the occasion of Microland’s 35th anniversary, Pradeep Kar, Founder, Chairman, and Managing Director, said, “Microland has evolved and matured over the last 35 years. Today, we are renewing our commitment to our clients, ensuring they connect with the best of tomorrow’s networking innovations today.”
About Microland
Microland is a pioneering IT Infrastructure services and consulting company headquartered in Bengaluru, India, with a proven track record of delivering tangible business outcomes for 35 years. Today, as enterprises recognize that networks underpin the functionality and efficiency of modern digital systems and support innovation, we provide next-generation technologies such as AI, automated operations, and platform-driven solutions – which drive operational excellence, agility, and productivity for organizations worldwide. Our team of over 4,600 experts delivers services in over 100 countries across Asia, Australia, Europe, the Middle East, and North America, offering cutting-edge solutions in networks, cloud, data centers, cybersecurity, services management, applications, and automation. Recognized by leading industry analysts for our innovative strategies, Microland is committed to strong governance, environmental sustainability, and fostering an inclusive workplace where diverse talent thrives. When businesses work with Microland, they connect with the best talent, technologies, and solutions to create unparalleled value. 
For more information, visit www.microland.com
Contact: [email protected]
Logo: https://mma.prnewswire.com/media/2488252/Microland_35_years_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/celebrating-35-years-of-innovation-microland-marks-milestone-with-groundbreaking-solutions-and-vision-for-the-future-302229985.html

The Cell Counting Market is driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in automated cell counting technologies. Expanding research in life sciences and biotechnology also boosts market growth. However, high costs of advanced instruments, stringent regulatory frameworks, and the lack of skilled professionals in developing regions are significant restraints that could hinder the market’s expansion.
LEWES, Del., Aug. 23, 2024 /PRNewswire/ — The Global Cell Counting Market Size is projected to grow at a CAGR of 6.20% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 10.2 Billion in 2024 and is expected to reach USD 16.5 Billion by the end of the forecast period.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=29479
Browse in-depth TOC on “Global Cell Counting Market Size”
202 – Pages126 – Tables37 – Figures
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2021-2031
GROWTH RATE
CAGR of ~6.20% from 2024 to 2031
BASE YEAR FOR VALUATION
2024
HISTORICAL PERIOD
2021-2023
FORECAST PERIOD
2024-2031
QUANTITATIVE UNITS
Value in USD Billion
REPORT COVERAGE
Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis
SEGMENTS COVERED

ProductApplicationEnd-User 
REGIONS COVERED

North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa 
KEY PLAYERS
Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company (BD), Merck KGaA, Agilent Technologies, Danaher Corporation, PerkinElmer, Inc., GE Healthcare, Beckman Coulter (a Danaher company), Olympus Corporation, Sysmex Corporation, Miltenyi Biotec, Nexcelom Bioscience, ChemoMetec A/S, DeNovix, Inc., Countstar, Abbott Laboratories, Tecan Group Ltd., Sartorius AG, Promega Corporation
CUSTOMIZATION
Report customization along with purchase available upon request
Global Cell Counting Market Overview
Advancements in Automated Cell Counting Technologies: The Cell Counting Market is experiencing strong expansion as a result of advancements in automated cell counting technology. Advancements in precision, velocity, and user-friendliness are diminishing human mistakes, enhancing the efficiency of tasks, and facilitating the analysis of large volumes of data. These advancements are increasing the demand from biotechnology companies and research laboratories, speeding up the growth of the market and promoting additional investment in automation solutions. The influence is clearly observable in the market’s increasing rate of adoption and continuous expansion.
Rising Prevalence of Chronic Diseases: The rising incidence of chronic illnesses, such as cancer and diabetes, is a major factor contributing to the growth of the Cell Counting Market. The increasing demand for early diagnosis and individualized therapy necessitates accurate cell counting in diagnostic techniques. The current increase in demand is driving the expansion of the market, especially in clinical laboratories and hospitals, where precise cell quantification is crucial for efficient patient care.
Growing Biopharmaceutical Research & Development: Increasing investment in research & development in the biopharmaceutical sector plays a vital role in driving the growth of the Cell Counting Market. The increasing investment by biopharma companies in the development of new medications and cures has led to a growing demand for dependable cell counting technologies in order to ensure precise research results. The increasing popularity of this trend is driving market expansion, directly influencing the use of sophisticated cell counting devices and reagents, resulting in higher sales and market reach.
High Costs of Advanced Cell Counting Instruments: Although sophisticated cell counting devices offer advantages, the substantial expenses connected with them present a significant obstacle in the Cell Counting Market. Smaller research labs and healthcare facilities sometimes struggle to afford these costly technology, which hinders their ability to enter the market. The presence of this financial obstacle is impeding the expansion of the market, particularly in developing areas where limited financial resources are more evident, thereby affecting the overall rate of acceptance.
Stringent Regulatory Requirements: The Cell Counting Market is further hindered by strict regulatory standards that govern the approval and usage of cell counting devices. Manufacturers may experience delays in product launches and incur higher costs due to the intricate and time-consuming nature of regulatory compliance. These limitations impede the expansion of the industry by restricting the accessibility of groundbreaking items and establishing obstacles for new participants in the market.
Limited Technical Expertise: The Cell Counting Market is limited by a scarcity of proficient people with skills in running sophisticated cell counting technologies. The absence of technical expertise can result in subpar utilization of these advanced devices, diminishing their efficacy and discouraging potential purchasers. The effect on market expansion is substantial, especially in areas with limited availability of specialist training and education, which hinders the rate of acceptance.
Key Players
The “Global Cell Counting Market” study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company (BD), Merck KGaA, Agilent Technologies, Danaher Corporation, PerkinElmer, Inc., GE Healthcare, Beckman Coulter (a Danaher company), Olympus Corporation, Sysmex Corporation, Miltenyi Biotec, Nexcelom Bioscience, ChemoMetec A/S, DeNovix, Inc., Countstar, Abbott Laboratories, Tecan Group Ltd., Sartorius AG, Promega Corporation.
Based on the research, Verified Market Research has segmented the global Cell Counting Market into Product, Application, End-User, and Geography.
Cell Counting Market, by Product:InstrumentsSpectrophotometersFlow CytometersHemocytometersAutomated Cell CountersMicroscopesConsumables & AccessoriesReagentsMicroplatesCell Counting Market, by Application:Complete Blood CountAutomated Cell CountersManual Cell CountersStem Cell ResearchCell-Based TherapeuticsBioprocessingToxicologyCell Counting Market, by End-User:Hospitals & Diagnostic LaboratoriesResearch & Academic InstitutesPharmaceutical & Biotechnology CompaniesCell Counting Market, by GeographyNorth AmericaU.SCanadaMexicoEuropeGermanyFranceU.KRest of EuropeAsia PacificChinaJapanIndiaRest of Asia PacificROWMiddle East & AfricaLatin AmericaBrowse Related Reports:
Global Cell-Based Drug Discovery Services Market Size By Type (Cell Line Development, Cell-Based Assays, Cell Culture, High-Content Screening, Phenotypic Screening), By Application (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders, Autoimmune Diseases), By Technology (2D Cell Culture, 3D Cell Culture, CRISPR/Cas9 Genome Editing, Single-Cell Analysis), By End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Geography, And Forecast
Global Live Cell Encapsulation Market Size by Type (Natural Polymers, Synthetic Polymers), By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation), By Method (Microencapsulation, Macroencapsulation, Nanoencapsulation), By Geography, And Forecast
Global Cell Separation Technology Market Size By Product Type (Consumables, Instruments), Application (Stem Cell Research, Cancer Research, Immunology, Drug Discovery and Development), End-User (Biotechnology and Pharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Clinics), By Geography, And Forecast
Global Cell Expansion Market Size By Cell Type (Human Cells, Animal Cells), Application (Regenerative Medicine and Stem Cell Research, Cancer & Cell-Based Research), & End-User (Biopharmaceutical & Biotechnology Companies, Research Institutes), By Geography, And Forecast
Top 7 Cell Culture Companies helping scientific community by growing cells in artificial environment
Visualize Cell Counting Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.
With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.
VMR’s domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.
Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR’s dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.
Contact Us
Mr. Edwyne FernandesVerified Market Research®US: +1 (650)-781-4080US Toll Free: +1 (800)-782-1768Email: mailto:[email protected]: https://www.verifiedmarketresearch.com/Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/cell-counting-market-is-expected-to-generate-a-revenue-of-usd-16-5-billion-by-2031–globally-at-6-20-cagr-verified-market-research-302229452.html

Advertisement

SHENZHEN, China, Aug. 23, 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”) is pleased to announce its plans to participate in a series of internationally recognized medical fairs and medical conferences. These forthcoming events will provide a valuable opportunity for UTime to showcase its latest achievements in medical devices and solutions and to enhance its communication and partnerships within the global medical industry.

At the upcoming MEDICA in Düsseldorf, Germany, one of the world’s most influential medical trade fairs for medical technology and devices, UTime plans to exhibit its latest innovations in medical monitoring devices and smart diagnostic tools. The Company’s exhibition booth aims to highlight its pioneering practices across the entire value chain of medical technology products.
In addition to MEDICA, UTime plans to attend the Cardiology Society Conference, Sleep Conference, and Hypertension Conference in the United States. These conferences gather leading medical experts and scholars, offering UTime not only a platform to present its technological advancements to the industry but also an excellent opportunity to learn and derive insights from global peers.
These planned participations underscore UTime’s ongoing commitment to influencing the global medical and healthcare landscape and demonstrate the Company’s mission to enhance human health through technological innovation.
UTime also intends to explore potential collaborative projects with various international healthcare organizations and research institutes, particularly in the areas of telemedicine and the application of artificial intelligence in healthcare. Through these international collaborations, the Company aims to accelerate the global rollout of its products, ultimately benefiting patients worldwide.
About UTime Limited
UTime is committed to transforming health and wellness through innovative medical wearable technologies. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management on a global scale. For more information, visit the Company’s website at http://www.utimeworld.com/. 
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the “Risk Factors” section of the Company’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission on July 30, 2024. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact:Eaky [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/utime-limited-to-participate-in-international-medical-fairs-and-medical-conferences-302229411.html